Britannica
Sources used in this answer
How does bioinformatics help scientists identify links between gene sequences and diseases?
Created from Britannica articles
using AI.
AI can make mistakes, so verify using Britannica articles.
bioinformatics
This computerized image of anthrax shows the various structural relationships of seven units within the protein and demonstrates the interaction of a drug (shown in yellow) bound to the protein to block the so-called lethal factor unit. Bioinformatics plays an important role in enabling scientists to predict where a drug molecule will bind within a protein, given the individual structures of the molecules.
Bioinformatics is a hybrid science that integrates biological data with computational techniques to analyze and interpret complex genetic information. It plays a critical role in identifying links between gene sequences and diseases through several key methods:
- Genome-Wide Association Studies (GWAS): This systematic approach scans the human genome to identify associations between specific genetic variationsāoften single nucleotide polymorphisms (SNPs)āand particular diseases. By comparing large datasets from patients with a disease against healthy controls, researchers can pinpoint genetic factors that contribute to disease risk.1
- Sequence Analysis and Annotation: Bioinformatics tools use algorithms to scan DNA sequences for genes and predict their functions. By comparing a newly identified sequence with known gene sequences in other organismsāleveraging evolutionary conservationāscientists can annotate potential disease-related functions for previously unassigned genes.234
- Data Integration: By mining vast amounts of genomic and "omics" data (such as transcriptomics and proteomics), bioinformatics allows researchers to understand how combinations of genetic variations influence biological pathways and disease states.2
These computational capabilities enable scientists to move from raw sequence data to identifying clinical applications, such as predicting disease risk and tailoring treatments to individual patients.21